Large Language Models-Enabled Digital Twins for Precision Medicine in Rare Gynecological Tumors

Fuente: arXiv
Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lammert, Jacqueline, Pfarr, Nicole, Kuligin, Leonid, Mathes, Sonja, Dreyer, Tobias, Modersohn, Luise, Metzger, Patrick, Ferber, Dyke, Kather, Jakob Nikolas, Truhn, Daniel, Adams, Lisa Christine, Bressem, Keno Kyrill, Lange, Sebastian, Schwamborn, Kristina, Boeker, Martin, Kiechle, Marion, Schatz, Ulrich A., Bronger, Holger, Tschochohei, Maximilian
Format: Preprint
Publié: 2024
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1866912825528549376
author Lammert, Jacqueline
Pfarr, Nicole
Kuligin, Leonid
Mathes, Sonja
Dreyer, Tobias
Modersohn, Luise
Metzger, Patrick
Ferber, Dyke
Kather, Jakob Nikolas
Truhn, Daniel
Adams, Lisa Christine
Bressem, Keno Kyrill
Lange, Sebastian
Schwamborn, Kristina
Boeker, Martin
Kiechle, Marion
Schatz, Ulrich A.
Bronger, Holger
Tschochohei, Maximilian
author_facet Lammert, Jacqueline
Pfarr, Nicole
Kuligin, Leonid
Mathes, Sonja
Dreyer, Tobias
Modersohn, Luise
Metzger, Patrick
Ferber, Dyke
Kather, Jakob Nikolas
Truhn, Daniel
Adams, Lisa Christine
Bressem, Keno Kyrill
Lange, Sebastian
Schwamborn, Kristina
Boeker, Martin
Kiechle, Marion
Schatz, Ulrich A.
Bronger, Holger
Tschochohei, Maximilian
contents Rare gynecological tumors (RGTs) present major clinical challenges due to their low incidence and heterogeneity. The lack of clear guidelines leads to suboptimal management and poor prognosis. Molecular tumor boards accelerate access to effective therapies by tailoring treatment based on biomarkers, beyond cancer type. Unstructured data that requires manual curation hinders efficient use of biomarker profiling for therapy matching. This study explores the use of large language models (LLMs) to construct digital twins for precision medicine in RGTs. Our proof-of-concept digital twin system integrates clinical and biomarker data from institutional and published cases (n=21) and literature-derived data (n=655 publications with n=404,265 patients) to create tailored treatment plans for metastatic uterine carcinosarcoma, identifying options potentially missed by traditional, single-source analysis. LLM-enabled digital twins efficiently model individual patient trajectories. Shifting to a biology-based rather than organ-based tumor definition enables personalized care that could advance RGT management and thus enhance patient outcomes.
format Preprint
id arxiv_https___arxiv_org_abs_2409_00544
institution arXiv
publishDate 2024
record_format arxiv
spellingShingle Large Language Models-Enabled Digital Twins for Precision Medicine in Rare Gynecological Tumors
Lammert, Jacqueline
Pfarr, Nicole
Kuligin, Leonid
Mathes, Sonja
Dreyer, Tobias
Modersohn, Luise
Metzger, Patrick
Ferber, Dyke
Kather, Jakob Nikolas
Truhn, Daniel
Adams, Lisa Christine
Bressem, Keno Kyrill
Lange, Sebastian
Schwamborn, Kristina
Boeker, Martin
Kiechle, Marion
Schatz, Ulrich A.
Bronger, Holger
Tschochohei, Maximilian
Computation and Language
Artificial Intelligence
Quantitative Methods
Machine Learning
Rare gynecological tumors (RGTs) present major clinical challenges due to their low incidence and heterogeneity. The lack of clear guidelines leads to suboptimal management and poor prognosis. Molecular tumor boards accelerate access to effective therapies by tailoring treatment based on biomarkers, beyond cancer type. Unstructured data that requires manual curation hinders efficient use of biomarker profiling for therapy matching. This study explores the use of large language models (LLMs) to construct digital twins for precision medicine in RGTs. Our proof-of-concept digital twin system integrates clinical and biomarker data from institutional and published cases (n=21) and literature-derived data (n=655 publications with n=404,265 patients) to create tailored treatment plans for metastatic uterine carcinosarcoma, identifying options potentially missed by traditional, single-source analysis. LLM-enabled digital twins efficiently model individual patient trajectories. Shifting to a biology-based rather than organ-based tumor definition enables personalized care that could advance RGT management and thus enhance patient outcomes.
title Large Language Models-Enabled Digital Twins for Precision Medicine in Rare Gynecological Tumors
topic Computation and Language
Artificial Intelligence
Quantitative Methods
Machine Learning
url https://arxiv.org/abs/2409.00544